Eslicarbazepine
- Level
- Commodity
- Parent
- 51141500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51141556This classification denotes an anticonvulsant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S5VXA428R4. European Medicines Agency schedules Eslicarbazepine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB27751. Eslicarbazepine generally arises in the molecular formula C15H14N2O2. The term ESLICARBAZEPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, no. 1, 2005, list 53.) Most nations schedule Eslicarbazepine under HS 29339930 and SITC 51577. As of Q4 2014, ESLICARBAZEPINE remains the US FDA Preferred Term for this commodity. Eslicarbazepine bears US NLM identifiers UMLS ID C2725260 and NCI Concept Code C81473. SMILES: C1CCC2C(C1)C[C@@H](C3CCCCC3N2C(=O)N)O.
Same parent
Under 51141500 · 80Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.